Journal of Investigative Medicine High Impact Case Reports (Apr 2024)

Marginal Zone Lymphoma Manifesting as Macrophage Activation Syndrome: A Case Report

  • Niloufar Ebrahimi MD,
  • Sahibzadi Mahrukh Noor MD,
  • Shahram Kordasti MD,
  • Mojtaba Akhtari MD,
  • Sayna Norouzi MD,
  • Mehrbod Vakhshoori MD,
  • Amir Abdipour MD

DOI
https://doi.org/10.1177/23247096241244732
Journal volume & issue
Vol. 12

Abstract

Read online

Macrophage activation syndrome (MAS) is a form of secondary hemophagocytic lymphohistiocytosis (HLH) when it occurs in the context of rheumatologic disorders. HLH is a rare and potentially life-threatening syndrome characterized by excessive immune system activation. It is mainly seen in children and can be genetic based or related to infections, malignancies, rheumatologic disorders, or immunodeficiency syndromes. MAS can present with nonspecific symptoms, leading to a delay in diagnosis. This report describes a case of a 64-year-old female with marginal zone lymphoma and systemic lupus erythematosus who presented with a purpuric rash and acute kidney injury. She underwent a kidney biopsy and was diagnosed with MAS. This case highlights the importance of promptly recognizing MAS’s symptoms and signs, allowing timely diagnosis and early therapeutic intervention. This potentially fatal condition tends to respond well to rapid treatment initiation with corticosteroids and to address the underlying condition.